1. Leo Pharma Taps Banks for Potential Copenhagen IPO, Eyeing 2024 Market Entry
Danish pharmaceutical firm Leo Pharma has taken a decisive step toward a public listing, selecting investment banks to lead a potential initial public offering on the Copenhagen stock exchange. The move signals a significant strategic shift for the privately held, family-backed company, with sources indicating a listin...